Breast Imaging Market Growing at a CAGR of 8.0% | Breast Imaging Technologies Market : Driver and Restraint

Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.

The breast imaging market is projected to grow from an estimated USD 3.1 billion in 2018 to USD 4.6 billion by 2023, at a CAGR of 8.0% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897&utm_source=openpr-19-2-20&utm_medium=openpr

Growing incidence of breast cancer

Breast cancer is among the most common cancers affecting women in developed as well as developing countries. According to the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths in women across the globe. In the US, one in eight women develops invasive breast cancer over the course of her lifetime. Similarly, on an average, 72 Canadian women were diagnosed with breast cancer every day.

The growing incidence of breast cancer cases leads to an increased burden on governments to raise awareness about the importance of early detection of breast cancer. Thus, with the sharp rise in breast cancer cases, the demand for breast imaging solutions is expected to grow considerably in the coming years.

High Cost of Breast Imaging Systems

Breast imaging systems are priced at a premium and require high investments for installations, which increases the procedural cost for patients as well. This affects the adoption rate of new systems, especially in emerging countries; most healthcare facilities in these countries, consequently, cannot afford such systems.

Healthcare facilities that purchase such costly systems often depend on third-party payers for reimbursements for costs incurred in screening and diagnostic procedures performed with these systems. Due to the high cost of these systems and budget constraints, healthcare facilities are reluctant to invest in new or technologically advanced systems.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=897&utm_source=openpr-19-2-20&utm_medium=openpr

Geographical Region Covered

Geographically, the breast imaging market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The Asia Pacific is one of the major high growth revenue-generating regions in the breast imaging market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries focusing on the improvement of breast health. Furthermore, the increasing geriatric population and the growing incidence of breast cancer are also driving the growth of this regional market.

Leading Companies

Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), FUJIFILM Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCin�, Inc. (US), and SuperSonic Imagine (France). Major 15 players covered.

Contact Us:
Mr. Sanjay Gupta
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL�60062
USA: +1-888-600-6441
Email:�sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com

About MarketsandMarkets(TM)
MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.